Posted by Michael Wonder on 27 Oct 2023
Organon Canada announces availability of a high concentration, citrate free formulation of Hadlima, a biosimilar to Humira
26 October 2023 - Hadlima 40 mg/0.4 mL offers a higher concentration compared to Hadlima 40 mg/0.8 mL.
Organon Canada today announced the availability of Hadlima (adalimumab), a biosimilar for Humira (adalimumab), in a high-concentration, citrate free (40 mg/0.4 mL) version.
